belumosudil
News/ News/ News/ Oncology/ R&D
Kadmon preps filing for GVHD drug belumosudil after phase 3 win
Phil Taylor
belumosudil, bone marrow transplant, graft versus host disease, immunology, Kadmon, Oncology
0 Comment
X
Kadmon preps filing for GVHD drug belumosudil after phase 3 win
https://pharmaphorum.com/news/kadmon-preps-filing-for-gvhd-drug-belumosudil-after-phase-3-win/